ZA981729B - Use of pivagabin to prepare pharmaceutical compositions - Google Patents
Use of pivagabin to prepare pharmaceutical compositionsInfo
- Publication number
- ZA981729B ZA981729B ZA981729A ZA981729A ZA981729B ZA 981729 B ZA981729 B ZA 981729B ZA 981729 A ZA981729 A ZA 981729A ZA 981729 A ZA981729 A ZA 981729A ZA 981729 B ZA981729 B ZA 981729B
- Authority
- ZA
- South Africa
- Prior art keywords
- pivagabin
- pharmaceutical compositions
- prepare pharmaceutical
- prepare
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- SRPNQDXRVRCTNK-UHFFFAOYSA-N pivagabine Chemical compound CC(C)(C)C(=O)NCCCC(O)=O SRPNQDXRVRCTNK-UHFFFAOYSA-N 0.000 title 1
- 229960003084 pivagabine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97MI000456A IT1290003B1 (en) | 1997-03-03 | 1997-03-03 | USE OF PIVAGABINA TO PREPARE PHARMACEUTICAL COMPOSITIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA981729B true ZA981729B (en) | 1998-08-28 |
Family
ID=11376246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA981729A ZA981729B (en) | 1997-03-03 | 1998-03-02 | Use of pivagabin to prepare pharmaceutical compositions |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JP2001513800A (en) |
| AR (1) | AR011907A1 (en) |
| AU (1) | AU7031798A (en) |
| IL (1) | IL131355A0 (en) |
| IT (1) | IT1290003B1 (en) |
| WO (1) | WO1998038988A1 (en) |
| ZA (1) | ZA981729B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR031473A1 (en) * | 2000-11-20 | 2003-09-24 | Lundbeck & Co As H | GABA INTENSIFIERS IN THE TREATMENT OF DISEASES RELATED TO A REDUCED NEUROSTEROID ACTIVITY |
| US7632836B2 (en) | 2006-11-30 | 2009-12-15 | Cenerx Biopharma, Inc. | Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| US11021430B2 (en) * | 2016-04-05 | 2021-06-01 | Moresco Corporation | Oxa acid compound |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1202402B (en) * | 1977-06-01 | 1989-02-09 | Galzigna Lauro | Hydrophobic derivs. of 4-aminobutyric acid |
-
1997
- 1997-03-03 IT IT97MI000456A patent/IT1290003B1/en active IP Right Grant
-
1998
- 1998-02-25 JP JP53816898A patent/JP2001513800A/en active Pending
- 1998-02-25 IL IL13135598A patent/IL131355A0/en unknown
- 1998-02-25 WO PCT/EP1998/001279 patent/WO1998038988A1/en active Application Filing
- 1998-02-25 AU AU70317/98A patent/AU7031798A/en not_active Abandoned
- 1998-03-02 ZA ZA981729A patent/ZA981729B/en unknown
- 1998-03-02 AR ARP980100917A patent/AR011907A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR011907A1 (en) | 2000-09-13 |
| JP2001513800A (en) | 2001-09-04 |
| WO1998038988A1 (en) | 1998-09-11 |
| IT1290003B1 (en) | 1998-10-19 |
| AU7031798A (en) | 1998-09-22 |
| IL131355A0 (en) | 2001-01-28 |
| ITMI970456A1 (en) | 1998-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA987552B (en) | Pharmaceutical composition for combination of piperidino-alkanol-decongestant | |
| IL138032A0 (en) | Pharmaceutical composition of topiramate | |
| HU9901570D0 (en) | Use of nanodispersions in pharmaceutical compositions | |
| IL136086A0 (en) | New composition of matter | |
| ZA984127B (en) | New composition of matter | |
| HUP0002512A3 (en) | Medicinal compositions for application to mucosa | |
| PT1073416E (en) | Use of inhaled no as anti-inflammatory agent | |
| HUP0203311A3 (en) | New pharmaceutical compositions of prolonged effect | |
| CY2569B1 (en) | Pharmaceutical compositions | |
| HUP9904290A3 (en) | Illudin analogs useful as antitumor agents and pharmaceutical compositions containing them | |
| HU9701080D0 (en) | Pharmaceutical composition of antiviral activity | |
| HUP0001858A3 (en) | Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same and the use of the compounds | |
| HUP0003159A3 (en) | The use of n-monosubstituted-3-oxo-4-aza-5alpha-androst-1-en-17betha-carboxamides for the preparation of pharmaceutical compositions | |
| IL131355A0 (en) | Use of pivagabin to prepare pharmaceutical compositions | |
| HUP0200311A3 (en) | Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions | |
| HUP9900251A3 (en) | Pharmaceutical compositions containing hedgehog proteins and use of former compositions | |
| LT97046A (en) | Composition of aperitive ingredients | |
| HU9702369D0 (en) | Pharmaceutical composition of natural active components | |
| HUP0004274A3 (en) | Bispyrido-cycloheptane compounds and pharmaceutical compositions thereof | |
| GB9401638D0 (en) | New medicinal compositions of matter | |
| LT97045A (en) | Composition of aperitive ingredients | |
| GB9709824D0 (en) | Compositions of matter | |
| GB9712031D0 (en) | Compositions of matter | |
| ZA987961B (en) | Substituted carboxamidothiazoles their preparation and pharmaceutical compositions containing them | |
| GB9709825D0 (en) | New compositions of matter |